Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valerie Bee
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
JAMA Oncology
Cancer Research
Oncology
Related publications
HER2-ASCO-Guidelines
Der Pathologe
Forensic Medicine
Pathology
Quantitative Assessments and Clinical Outcomes in HER2 Equivocal 2018 ASCO/CAP ISH Group 4 Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Assessment of Dual-Probe Her-2 Fluorescent in Situ Hybridization in Breast Cancer by the 2013 ASCO/CAP Guidelines Produces More Equivocal Results Than That by the 2007 ASCO/CAP Guidelines
Breast Cancer Research and Treatment
Cancer Research
Oncology
HER2 (EGFR2; ErbB2; Neu)
Science-Business eXchange
HER2/ErbB2 Activates HSF1 and Thereby Controls HSP90 Clients Including MIF in HER2-overexpressing Breast Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Necessity of in Situ Hybridization Test of Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer Patients With Equivocal HER2 Immunohistochemistry Results
Journal of Breast Disease
HER2 (ERBB2; Neu); Transferrin Receptor
Science-Business eXchange
Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
Assessment of HER2 Status in Breast Cancer Biopsies Is Not Affected by Accelerated Tissue Processing
Histopathology
Medicine
Forensic Medicine
Pathology
Histology